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Some Aspects of Pyelonephritis
by J. McC. MURDOCH, F.R .C .P .E., M .R.C.P.Glas.,
Consultant Physician, City Hospital, Edinburgh;
Honorary Senior Lecturer in Medicine, University of Edinburgh.
In a short article it is only possible to outline 
the im portant advances in our knowledge of the 
serious and often fatal disease— pyelonephritis. 
T h is pathological entity has been well recogn­
ised since the nineteenth century but interest 
in its clinical aspects has only been aroused 
since the end of the second world war. Prior 
to this little attention was paid to pyelone­
phritis by clinical workers until the classical 
paper of Longcope (1937). T h e  disease is very 
protean in its presentation which makes a clear 
definition o f the term pyelonephritis difficult. 
Acute or chronic pyelonephritis m ay arise in 
normal kidneys by infection with m icro­
organisms or in kidneys structurally altered by 
prior disease processes or congenital m alform ­
ations.
P A T H O L O G Y
An adm irable review of the high incidence 
of pyelonephritis found post-mortem, undiag­
nosed in life in most cases and the direct cause 
of death in some, has recently been published 
(K leeman et al, 1960). Further, Danish statistics 
dem onstrate that the m ortality in females from 
pyelonephritis has shown a steep apparent in­
crease since 19 35  (M osbech, 1 960). Gram - 
negative infection of the fem ale urinary tract 
is notoriously com m on and acute disease caused 
by such infection may have been controlled to 
some extent by the introduction of sulphon- 
am ide and subsequent antibiotic therapy. Latent 
infection, however, m ay cither have gone un­
treated or the treatment was only partially 
effective, leading to chronic inflam m atory renal
disease and ultim ate death in many cases. 
W hen there is any form of obstruction to the 
urine outflow tract there is a m uch increased 
tendency to the developm ent of pyelonephritis. 
Discussion of the disease process in the elderly 
male with prostatic hypertrophy is not intended 
here.
A cute pyelonephritis is characterised by 
m inute scattered areas of acute polym orphic 
exudate in the intertubular interstitial spaces, 
few  in num ber in the early case but steadily 
increasing with recurrent attacks of infection. 
I f  the disease progresses towards chronicity 
there is a steady dim inution in glomerular tissue 
with marked renal fibrosis, atrophy and dilata­
tion of the tubules as seen in Figure 1. Pyelone­
phritis is usually bilateral with one kidney more 
grossly affected than the other.
E T IO L O G Y
Text-book descriptions o f the etiology of 
urinary tract infection and subsequent pyelone­
phritis suggest three theories: the carriage of 
organisms by the blood stream from the colon 
to the renal substance; ascending infection from 
the bladder mucosa by the peri-ureteric lym ­
phatics; or direct spread of organisms from the 
bladder via the ureteral lum en to the renal 
calyces. Experim ental work has attem pted to 
reproduce the disease in anim als by similar 
routes (V ivaldi et al, 1 960) and the bulk of 
evidence suggests that the third contention of 
direct spread of infection from the bladder via 
the ureters to the kidney is the com m onest 
route of infection, In human females the
Figure I.
Section of kidney removed from a 42-year-old 
multiparous female With a history of recurrent 
attacks of so-called pyelitis dating from her first 
pregnancy 19 years previously. This shows total 
absence of glomerular tissue and marked inter- 
tubular fibrosis with chronic inflammatory 
exudate throughout the field. There is striking 
dilatation of the tubules with atrophic epithelium. 
Colloid is seen in the tubular lumen — the so- 
called thyroid-like appearance characteristic of 
chronic pyelonephritis.
anterior urethra is normally colonised by grain- 
negative micro-organisms. Should these gain 
access to the bladder the urine is an excellent 
nidus for their rapid m ultiplication. If vesico- 
ureteric reflux mechanisms co-exist, and it is 
known that they are common from birth on­
wards. the organisms will be rapidly forced up 
one or both ureters to the kidneys themselves. 
Gross disturbance of vesico-ureteric function 
occurs in pregnancy, a fact known for almost 
thirty years (Baird, 19 36 ).
Escherichia coli is by far the commonest 
single infecting organism, being present alone 
in about 80 per cent of most published series. 
Other infecting species are proteus, pyocyanea, 
entcrococci and staphylococcus aureus, which 
are not usually found in the urinary tract in the 
absence of a history of bladder instrumentation. 
The urethral catheter was frequently passed 
during labour and in the puerperium until 
recent times. It can now be stated that cathe- 
terisation is neither necessary nor desirable for
the purpose of obtaining urine for bacteriology. 
C ath eterisation for therapeutic reasons must be 
carried out with scrupulous antisceptic tech­
niques to reduce the incidence of bladder 
infection to a minimum (Gillespie et al , 1962). 
There is a correlation between urinary tract 
infection and the subsequent developm ent of 
pyelonephritis, depending upon age and sex 
with young females predominating (Burke, 
19 6 1); with the developm ent of active sexual 
life and particularly with pregnancy; with other 
disease processes, especially diabetes m ellitus 
(Kalliom ake and Kasanen, 1960); and with con­
genital malformations— most com m only found 
in the genito-urinary tract. All patients develop­
ing a urinary tract infection will not necessarily 
go on to develop chronic pyelonephritis. At 
present, however, it cannot be prognosed as to 
which idividual will do so, since the immune 
mechanisms of pyelonephritis are very im per­
fectly understood (Beeson, 19 55 : G u ze, 19 6 1). 
In Edinburgh a large scale investigation of 
pregnant women has been undertaken in the 
past three years. Significant urinary tract in­
fection has been found in seven per cent, of 
primiparous women rising to over 20 per cent, 
in multipara. These findings correlate closely 
with the work of K ass in the United States 
(Kass, 1959). In schoolchildren the incidence 
of urinary tract infection is much higher in 
females than in males (K unin et al, 1962; K unin 
and H almagyi, 1962). Despite these findings, 
however, pyelonephritis is not invariably detec­
table in such patients. Indeed- the true 
incidence of urinary tract infections in the 
community as a whole is at present unknown 
but there is no doubt that they are common 
and not infrequently associated with renal 
disease. Long-term prospective studies must 
continue for many years to com e if the problem 
of pyelonephritis is to be elucidated.
C L IN IC A L , F E A T U R E S
T h e classical features of acute and chronic 
urinary tract infections are well known and will 
not be described further. As with so many other 
disease syndromes these probably account for 
only a minority of patients with infection of 
the urinary tract. For example, it is already 
known that pregnant women with significant 
bacteriuria arc asymptomatic or have mild 
urinary symptoms wrongly attributed to the 
effect of the pregnancy. Som e of these women 
will develop classical so-called acute pyelitis of 
pregnancy but by no means all will do so. About 
half of the infected pregnant women will still 
show evidence of persistent infection without
Symptoms after delivery. For these reasons the 
concept of screening urine for asymptomatic 
infection during pregnancy as a routine measure 
is becoming acceptable and it might be forecast 
that this will become just as much a routine 
examination as the chest radiograph or Rhesus 
factor estimation at the present time.
Female infants who show failure to thrive 
with episodes of unexplained fever, irritability, 
vom iting or diarrhoea should have the urine 
adequately cultured for evidence of infection. 
In the author’s own experience approximately 
50 such infants per year are referred to hospital 
with various diagnostic labels such as feeding 
upset, pyrexia of unknown origin or gastro­
enteritis. Unexplained hypertension in middle- 
aged women should lead to investigation of the 
renal tract for evidence of pyelonephritis and 
latent infection. T h e  urine should be regularly 
cultured as a routine measure in female 
diabetics. Chronic renal infection should be 
suspected in post-menopausal women with 
apparently unexplained refractory anaemia 
which has failed to respond to iron. Such 
anaemias are not necessarily associated with 
uraemia even when chronic pyelonephritis is 
moderately or well advanced. T h e  one import­
ant symptom which can be looked upon as 
highly suspicious of chronic renal tract infec­
tion is nocturia. Im pairm ent of tubular function 
leads to failure in the concentrating power of 
the kidneys and it is already known that many 
women, especially multipara, come to accept 
recurrent nocturia as their norm. This symptom 
will not be revealed, therefore, unless the 
patient is questioned directly. As a result of the 
nocturia continuous interruption of normal 
sleep will lead to general vague symptoms of 
daily tiredness, irritability and lassitude which 
may be wrongly attributed to other causes such 
as the menopause or domestic anxiety. The 
eradication of infection in such women often 
leads to reduction or abolition of night rising 
and so to prolonged sound sleep with great 
improvement in general health.
T h e  clinician must be aware of the common 
occurence of chronic urinary tract infection in 
females at all ages with minimal sym ptom ­
atology easily attributable to other processes and 
he should not diagnose “ menopausal neurosis” 
or idiopathic insomia before he has excluded 
this important infection.
D IA G N O S IS
T h e diagnosis of obvious acute urinary tract 
infections will be confirmed by the finding of 
pus and bacteria in freshly vo id ed specimens of
urine (Murdoch et al, 1959). This will be cul­
tured within 20 minutes of voiding or the urine 
should be refrigerated at 4 C until it is sent 
to the laboratory. There is controversy as to 
whether it is necessary to count the numbers of 
bacteria in the urine. This is a convenient 
measurement when the numbers exceed 100,000 
per ml. which is regarded as significant of 
infection, while those below this figure merely 
indicate contamination (Kass, 1957). The presence 
or absence of pus cells need not necess­
arily influence this diagnostic criterion. If 
bacteria are absent some authorities advocate 
the estimation of white cell excretion rates in 
urine (Houghton and Pears, 1957- : D e  W ard 
ener. 1960). This tedious and time-consuming 
procedure is of doubtful value in the diagnosis 
of chronic pyelonephritis whether or not steriod
Figure  2
In travenous  pye log ram  i n  a fem ale  aged 22 
years fo und  du r ing  her second pregnancy to have  
asym ptom atic  bacteriuria . T h i s  shows gross 
d istortion of a ll calyces w ith  characteristic  
“c lu bb in g " . There is m arked reduction and  
shrinkage  of the righ t rena l cortex. The left 
kidney is p a rtia lly  hypertroph ied  but also shows 
th in n in g  of the rena l cortex in its upper pole. 
The appearances are typ ical of advanced b ila te ra l 
chronic pyelonephritis .
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provocation is employed and it is not advocated 
as a routine measure (Kennedy et al, 1963a).
When chronic pyelonephritis exists without 
bacteriuria radiology is valuable in establishing 
the diagnosis when the disease is moderately or 
well advanced. Figure 2 illustrates the classical 
radiological features of advanced bilateral pye­
lonephritis in a young woman. Retrograde 
cystoscopy and pyelography may be necessary 
when calculus formation or other gross surgical 
defects are present or suspected. Voiding 
cystometrograms will demonstrate vesico- 
ureteric reflux (Hodson and Edwards, 1960) and 
aortography may occasionally be an added 
refinement to demonstrate vascular anomalies 
such as renal artery stenosis. Standard tests of 
renal function will usually be undertaken but 
these will have to be supplemented by more 
refined techniques when unilateral or bilateral 
surgery is contemplated. In large medical 
centres I131—labelled Hippuran excretion is 
being used to estimate individual kidney func­
tion more accurately. These refinements should 
not usually be necessary in the early case with­
out obvious disease of the renal cortex and this 
is when the clinician would prefer to diagnose 
pyelonephritis in order to obtain full clinical 
and bacteriological cure. Because the disease 
is so patchy percutaneous renal biopsy is 
unlikely to be successful in diagnosing pyelone­
phritis. The ideal time for diagnosis is in the 
early stage of renal infection long before im­
pairment of renal function can be detected by 
the crude techniques at present available. The 
clinician must learn to suspect the presence of a 
urinary tract infection in young women or 
children with vague ill-health. This will lead 
to urine culture which is almost invariably 
positive in the early stages of the disease. The 
differential diagnosis should not be difficult but 
if the urine is sterile renal tuberculosis must 
be excluded by appropriate culture. Other in­
flammatory renal diseases presenting with pyuria 
or haematuria should be readily excluded by 
other methods. Pyelonephritis is the common­
est renal disease encountered in European and 
North American women.
T R E A T M E N T
The treatment of urinary tract infections 
must be considered in two groups: first, the 
acute infection, and second, the chronic 
relapsing case.
The acute infection will most frequently be 
encountered in general practice where facilities 
for accurate diagnostic bacteriology' will not
always be readily available. The clinician can 
reasonably assume that the infecting organism 
will be E . coli in over 80 per cent of his pat­
ients. At the same time it is important for him 
to realise that these micro-organisms, even in 
general practice, will not invariably be sensitive 
to the sulphonamides. Recent studies in Edin­
burgh have shown that about 25 per cent of 
strains of E. coli from general practice sources 
are sulphonamide-resistant. Despite this many 
practitioners still elect to use a sulphonamide 
for the first acute infection even although there 
is a 25 per cent, chance that this treatment will 
be unsuccessful. Further objections to using the 
sulphonamides as drugs of first choice in this 
field are that they are bacteriostatic, acetylated 
in the liver, protein-bound and do not appear 
in urine in high concentration, especialy if this 
is diluted by ‘forcing fluids”  during treatment. 
There is the added risk of marrow toxicity, 
especially if long-acting sulphonamides arc 
given for prolonged periods. Chloramphenicol 
has obvious disadvantages and should not be 
used at all. The tetracyclines are bacteriostatic 
and many E. coli strains are tetracycline- 
resistant in the general population. During the 
past year it has been shown that the tetra­
cyclines cross the placental barrier readily and 
are deposited throughout the foetal skeleton. 
Thus it would seem unwise to give tetracyclines 
for urinary tract infections in pregnancy. The 
novobiocin and tetracycline combination is 
even more toxic and should not be used. 
Streptomycin is bactericidal for many E. coli 
strains but it must be given in the presence 
of a continuously alkaline urine—this is almost 
impossible to achieve in general practice. Nitro­
furantoin has enjoyed a popular reputation but 
it is interesting to speculate as to how many 
patients genuinely take this drug because of its 
capacity to produce heartburn and nausea even 
in moderate therapeutic doses. Recent reviews 
now indicate that more serious neurotoxicity 
and marrow toxicity can be produced by nitro­
furantoin, especially if it is given for prolonged 
periods. The ideal drug for the acute infection 
should be one which is bactericidal, uniformly 
absorbed from the gut after oral administration, 
giving high tissue and urine concentrations 
without toxicity. Such a drug docs not exist but 
cycloserine conics nearest to these theoretical 
requirements. A dose of 250 mg. twice daily for 
14 days will eradicate 95 per cent, of E . coli 
infections provided renal function and structure 
are normal (Syme et al, 1961). Cycloserine is 
toxic to the nervous system, producing drowsi­
ness, psychosis and even epileptiform convul-
sions if high blood and tissue levels arise as a 
result o f impaired renal function. T h is is un­
likely in the acute uncom plicated case but the 
drug should be withdrawn at the first sign of 
drowsiness— a toxic effect which is more easy 
to detect than, for example, bone marrow 
depression. Furthermore, cycloserine toxicity is 
com pletely reversible upon withdrawal of the 
drug. In summary it would seem that the 
general practitioner will use a sulphonamide as 
the drug of first choice but if this drug fails to 
eradicate the infection cycloserine should be 
considered as the drug of second choice for 
acute E . coli infections.
T h e  refractory or relapsing case presents an 
entirely different problem and it is important 
to ensure that the renal tract is fully investig­
ated to exclude calculus, obstruction or serious 
renal damage before administering any drug. 
Accurate bacteriology, of course, m ust supple­
m ent these investigations. T ab le  1 shows the 
antibiotic susceptibility of a large number of 
E . coli and other com m on urinary pathogens 
in the Edinburgh area studied over the past
mined by such factors individually. N ewer 
antibacterial drugs arc now available for the 
eradication of most pathogens encountered in 
the renal tract. C ycloserine is suitable for 95 per 
cent, of E . coli strains. 250 mg. tw ice daily will 
eradicate the organism and after 14 days the 
close can b e reduced to 250 m g. on alternate 
evenings for indefinite periods o f time, depend­
ing upon the presence of radiological pyelone­
phritis or, for example, vesico-ureteric reflux. 
Som e patients in Edinburgh have been taking 
suppressive cycloserine for up to three years 
with excellent bacteriological results. T h e 
relapse rate in a large series of patients is only 
five per cent. T h is compares very favourably 
with relapse rates of around 30 per cent, in 
other series treated w ith sulphonamides, nitro­
furantoin or mandelic acid. Cycloserine can also 
be given during pregnancy either for short 
courses or throughout the pregnancy. Studies 
of foetal cord blood and am niotic fluid after 
delivery in patients treated with this drug show 
that very little o f the antibiotic crosses the 
placental barrier. Cycloserine seems to be the
Organism No. of Isolates % strains RESISTANT in vitro to:
Su. S C T Novo. +  T NitroF.
E. coli ....................  495 66 32 8 89 98 4
Proteus spp.............  71 88 29 15 100 100 74
Klebsiella ...........  30 67 27 10 73 —  17
Ps. pyocyanes .......  30 100 100 90 93 — 100
Antibiotic sensitivity of urinary tract pathogens (Disk-Diffusion Method).
three years. In hospital, to which the refractory 
case eventually com es, the older and more 
traditional drugs do not show in vitro effective­
ness except in a small number of the isolates. 
T h e  treatment of such eases is not simply the 
administration of an antibacterial drug based 
on in vitro susceptibilities. Drainage defects 
must be corrected surgically, calculi must be 
removed where possible and nephrectomy, 
partial nephrectomy or bilateral partial neph­
rectomy may be required to remove non­
functioning areas of renal tissue before any 
drug can be expected to eradicate the infection. 
T h e  management of each case will be deter-
antibiotic of first choice for prolonged suppres­
sive therapy in patients suffering from estab­
lished chronic pyelonephritis or in young 
females who have demonstrable vesico-ureteric 
reflux. A t present it is impossible to say for 
how long the drug should be given but it would 
appear indicated until such tim e as the reflux 
has disappeared or indefinitely to patients who 
have only very little functioning renal tissue.
As will be seen from T able 1 proteus and 
klebsiella strains are resistant to standard forms 
of treatment. For fulm inating infections with 
these organisms, w ith or w ithout septicaemia, 
the antibiotic of first choice is kanamycin
sulphate given in a dose of 0.25 G. 6-hourly 
intra-muscularly for 14 days (Murdoch et al, 
1962). The indications and contra-indications 
for the use of kanamycin sulphate have been 
fully reviewed recently (Murdoch, 1962). 
Proteus mirabilis strains are not infrequently 
fully sensitive to the action of ampicillin which 
is, therefore, suitable for the treatment of acute 
infections with this organism in a dose of 500 
mg. 6-hourly for 14 days. Prolonger suppressive 
treatment with this antibiotic can be given in 
a dose of 250 mg. on alternate days (Kennedy 
et al, 1963b). Despite its early promise (Brum- 
fitt et al, 1962) ampicillin has been disappoint­
ing in the treatment of E. coli and most other 
gram-negative urinary tract infections. Pseudo- 
monas pyocyanea infections of the urinary tract 
are fortunately uncommon as they were in the 
past resistant to almost all forms of treatment 
(see Table 1). A close chemical relative of poly­
myxin B which is less neurotoxic—colistin 
methanesulphonate—is highly effective both 
in vitro and in vivo against pyocyanea infec­
tions and this antibiotic should be given in a 
minimum dose of 1.5 million units 8-hourly for 
14 days when it will usually eradicate the 
infection completely (Carroll and Malette, 1961; 
Courtieu et al, 1961). A note of caution is, 
however, necessary when using either kana­
mycin or colistin in the presence of impaired 
renal function. Dangerously high blood levels 
may then occur, giving rise to ototoxicity with 
kanamycin and peripheral paraesthesiae or even 
chemical encephalitis in the case of colistin. 
These antibiotics should only be given in the 
presence of uraemia where facilities are avail­
able for monitoring the blood levels of the 
antibiotics daily. Blood levels of kanamycin 
sulphate should not be allowed to rise above 
30mcg/ml. and of colistin above 64 mcg/ml. if 
neurotoxicity is to be avoided.
CONCLUSIONS
In recent years there has been an increasing 
awareness of the serious import of gram- 
negative infection of the urinary tract, espec­
ially in young and middle-aged females 
(Murdoch, 1963). In the past a casual attitude 
towards these infections has led to indifferent 
standards by which therapy has been judged. 
The emergence of drug-resistant pathogens has 
invitably occurred, especially in hospital 
practice, and inadequate standards of bacter­
iological cure have been adopted. Symptomatic 
cure of so-called cystitis is easy to achieve while 
bacteriological cure is much more difficult. This 
is especially the case when infection has become
established in the renal parenchyma itself. In 
the future it is to be hoped that treatment will 
be judged by adequate long-term evidence of 
bacteriological cure for the acute and apparently 
uncomplicated case while in the patient with 
established pyelonephritis long-term suppressive 
therapy will be adopted and controlled by 
adequate bacteriology. In essence the prevention 
of pyelonephritis is a theoretical possibility 
while in practice it is very difficult to achieve. 
This should not deter the clinician of the 
future from ensuring that apparently trivial 
infections of the urinary tract arc rigorously 
eradicated with modern bactericidal drugs and 
any evidence of relapse or reinfection will lead 
to full investigation of the renal tract to exclude 
“surgical’ disease. If such steps arc taken in the 
future the trend toward increasing morbidity 
and mortality from pyelonephritis will be 
reversed.
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